| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing
|
Deloughery, Thomas G.
|
|
|
6 |
4 |
p.
|
artikel
|
| 2 |
Are outpatient anticoagulation management services the wave of the future (again)?
|
Samuelson Bannow, Bethany
|
|
|
6 |
4 |
p.
|
artikel
|
| 3 |
Are women equal? Considering impact of therapeutic abortion bans on science
|
Cushman, Mary
|
|
|
6 |
4 |
p.
|
artikel
|
| 4 |
Assessing quality of life after pulmonary embolism: Comparing results from the PEmb‐QoL with semistructured interviews
|
Hernandez‐Nino, Jackeline
|
|
|
6 |
4 |
p.
|
artikel
|
| 5 |
Cancer‐associated venous thromboembolism in Israel: Incidence, risk factors, treatment, and health care utilization in a population based cohort study
|
Sharman Moser, Sarah
|
|
|
6 |
4 |
p.
|
artikel
|
| 6 |
Coagulation test understanding and ordering by medical trainees: Novel teaching approach
|
Gabarin, Nadia
|
|
|
6 |
4 |
p.
|
artikel
|
| 7 |
D‐dimer testing in clinical practice in the era of COVID‐19
|
Auditeau, Claire
|
|
|
6 |
4 |
p.
|
artikel
|
| 8 |
Developing and optimizing a computable phenotype for incident venous thromboembolism in a longitudinal cohort of patients with cancer
|
Li, Ang
|
|
|
6 |
4 |
p.
|
artikel
|
| 9 |
Economic impact of a rapid, on‐demand ADAMTS‐13 activity assay for the diagnosis of thrombotic thrombocytopenic purpura
|
White, Alicia
|
|
|
6 |
4 |
p.
|
artikel
|
| 10 |
Effect of lower‐leg trauma and knee arthroscopy on procoagulant phospholipid‐dependent activity
|
Touw, Carolina E.
|
|
|
6 |
4 |
p.
|
artikel
|
| 11 |
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
|
Trujillo‐Santos, Javier
|
|
|
6 |
4 |
p.
|
artikel
|
| 12 |
F8 gene mutation spectrum in severe hemophilia A with inhibitors: A large cohort data analysis from a single center in China
|
Sun, Jie
|
|
|
6 |
4 |
p.
|
artikel
|
| 13 |
Hemostasis and tumor immunity
|
Cantrell, Rachel
|
|
|
6 |
4 |
p.
|
artikel
|
| 14 |
Identification of von Willebrand factor D4 domain mutations in patients of Afro‐Caribbean descent: In vitro characterization
|
Dubois, Marie‐Daniéla
|
|
|
6 |
4 |
p.
|
artikel
|
| 15 |
“If I wasn't a girl”: Experiences of adolescent girls with heavy menstrual bleeding and inherited bleeding disorders
|
Parker, Mackenzie
|
|
|
6 |
4 |
p.
|
artikel
|
| 16 |
Immune‐mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressure
|
Joseph, Adrien
|
|
|
6 |
4 |
p.
|
artikel
|
| 17 |
Indeterminate serotonin release assays are associated with a high mortality rate
|
Jindal, Shawn
|
|
|
6 |
4 |
p.
|
artikel
|
| 18 |
Issue Information
|
|
|
|
6 |
4 |
p.
|
artikel
|
| 19 |
Management of cancer‐associated thrombosis with thrombocytopenia: Impact of the ISTH guidance statement
|
Held, Nicole
|
|
|
6 |
4 |
p.
|
artikel
|
| 20 |
Molecular analysis of vascular gene expression
|
Van der Ent, Martijn A.
|
|
|
6 |
4 |
p.
|
artikel
|
| 21 |
No association of low‐dose aspirin with severe COVID‐19 in France: A cohort of 31.1 million people without cardiovascular disease
|
Botton, Jérémie
|
|
|
6 |
4 |
p.
|
artikel
|
| 22 |
Novel interaction of properdin and coagulation factor XI: Crosstalk between complement and coagulation
|
Heal, Samantha L.
|
|
|
6 |
4 |
p.
|
artikel
|
| 23 |
Physician perceptions and use of reduced‐dose direct oral anticoagulants for extended phase venous thromboembolism treatment
|
Groat, Danielle
|
|
|
6 |
4 |
p.
|
artikel
|
| 24 |
Prophylactic fresh frozen plasma versus prothrombin complex concentrate for preprocedural management of the coagulopathy of liver disease: A systematic review
|
Evans, Christina R.
|
|
|
6 |
4 |
p.
|
artikel
|
| 25 |
Pulmonary embolism and deep vein thrombosis—comorbidities and temporary provoking factors in a register‐based study of 1.48 million people
|
Glise Sandblad, Katarina
|
|
|
6 |
4 |
p.
|
artikel
|
| 26 |
Quantification of emicizumab by mass spectrometry in plasma of people with hemophilia A: A method validation study
|
Donners, Anouk A.M.T.
|
|
|
6 |
4 |
p.
|
artikel
|
| 27 |
Recombinant porcine factor VIII corrects thrombin generation in vitro in plasma from patients with congenital hemophilia A and inhibitors
|
Négrier, Claude
|
|
|
6 |
4 |
p.
|
artikel
|
| 28 |
Seroprevalence to adeno‐associated virus type 6 in people with hemophilia B from a UK adult cohort
|
Boyce, Sara
|
|
|
6 |
4 |
p.
|
artikel
|
| 29 |
Sex‐specific aspects of venous thromboembolism: What is new and what is next?
|
Scheres, Luuk J.J.
|
|
|
6 |
4 |
p.
|
artikel
|
| 30 |
The Journey to a Successful Illustrated Review
|
Nersesian, Sarah
|
|
|
6 |
4 |
p.
|
artikel
|
| 31 |
Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID‐19: The Swiss COVID‐HEP randomized clinical trial
|
Blondon, Marc
|
|
|
6 |
4 |
p.
|
artikel
|
| 32 |
Thrombolytic therapy in cardiac arrest caused by cardiac etiologies or presumed pulmonary embolism: An updated systematic review and meta‐analysis
|
Alshaya, Omar A.
|
|
|
6 |
4 |
p.
|
artikel
|
| 33 |
Thrombotic thrombocytopenia After Sinopharm BBIBP‐CorV COVID‐19 vaccination
|
Hosseinzadeh, Rezvan
|
|
|
6 |
4 |
p.
|
artikel
|
| 34 |
Tissue factor release following traumatic brain injury drives thrombin generation
|
Hubbard, W. Brad
|
|
|
6 |
4 |
p.
|
artikel
|
| 35 |
To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question
|
Bikdeli, Behnood
|
|
|
6 |
4 |
p.
|
artikel
|
| 36 |
Vaccine‐induced prothrombotic immune thrombocytopenia without thrombosis may not require immune modulatory therapy: A case report
|
Lai, Chieh Min Benjamin
|
|
|
6 |
4 |
p.
|
artikel
|
| 37 |
Venous thrombosis in evacuees during war: Will the experience of our ancestors be put to good use?
|
Sueta, Daisuke
|
|
|
6 |
4 |
p.
|
artikel
|
Tijdschrift beschrijving